Drugs / diphtheria-tetanus-acellular pertussis vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04053010 | Aug → Dec 2019 | — | China National Biotec Group Company Limited | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | diphtheria-tetanus-acellular pertussis vaccine | “Immunogenicity and safety of co-administration with the Sabin-strain-based inactivated poliovirus vaccine (vero cell) and the diphtheria-tetanus-acellular pertussis vaccine in...” PMID 40969746 ↗ Sep 2025 |
| Known as | DTaP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04053010 ↗ |
| Modality | Vaccine | “diphtheria-tetanus-acellular pertussis vaccine” PMID 40969746 ↗ Sep 2025 |